ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy.

Zhuo-Kun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.